Geom Therapeutics' Series A Round

Geom Therapeutics raised a round of funding on April 11, 2017. Investors include Aisling Capital.

Geom Therapeutics is a biotechnology company focused on the development of novel antibiotics for multidrug-resistant Gram-negative infections. GT-1 is a highly differentiated antibiotic that provides …

Articles about Geom Therapeutics' Series A Round: